HER2/Neu and the Ets transcription activator PEA3 are coordinately upregulated in human breast cancer

Oncogene

Volumn 15, Issue 13, 1997, Pages 1513-1525

  Benz, Christopher C ^a   O'Hagan, Ronan C ^b   Richter, Birgit ^a   Scott, Gary K ^a   Chang, Chuan Hsiung ^a   Xiong, Xiaohui ^a   Chew, Karen ^a   Ljung, Britt Marie ^a   Edgerton, Susan ^c   Thor, Ann ^c   Hassell, John A ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MCMASTER UNIVERSITY   (Canada)

^c UNIVERSITY OF VERMONT   (United States)

Author keywords

Breast cancer; Ets transcription factor; HER2 Neu; PEA3

Indexed keywords

MESSENGER RNA; PROTEIN TYROSINE KINASE; PROTEINASE; TRANSCRIPTION FACTOR;

ARTICLE; BINDING SITE; BREAST CANCER; CANCER GENETICS; CANCER GROWTH; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DNA TRANSCRIPTION; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; ONCOGENE NEU; PRIORITY JOURNAL; PROMOTER REGION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

EID: 9844250762     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1201331     Document Type: Article

References (49)

1. Bailly R-A, Bosselut R, Zucman J, Cormier F, Delattre O, Roussel M, Thomas G and Ghysdael J. (1994). Mol. Cell. Biol., 14, 3230-3241.
2. Ben-Levy R, Paterson HF, Marshall CJ and Yarden Y. (1994). EMBO J., 13, 3302-3311.
3. Benz CC, Scott GK, Sarup JC, Johnson RM, Tripathy D, Coronado E, Shepard HM and Osborne CK. (1992). Breast Cancer Res. Treat., 24, 85-95.
4. Benz CC, Brandt BH and Zänker KS. (1995). Gene, 159, 3-7.
5. Bosher JM, Williams T and Hurst HC. (1995). Proc. Natl. Acad. Sci., 92, 744-747.
6. Bosher JM, Totty NF, Hsuan JJ, Williams T and Hurst HH. (1996). Oncogene, 13, 1701-1707.
7. Brown TA and McKnight SL. (1992). Genes & Devel., 6, 2502-2512.
8. Cahill MA, Janknecht R and Nordheim A. (1996). Current Biology, 6, 16-19.
9. Dankort DL and Muller WJ. (1996). Mammary Tumor Cell Cycle, Differentiation and Metastasis. Dickson R and Lippman M. (eds). Kluwer Academic Publishers, pp. 71-78.
10. Delattre O, Zucman J, Plougastel B, Desmaze C, Melot T, Peter M, Kovar H, Joubert I, de Jong P, Rouleau G, Aurias A and Thomas G. (1992). Nature, 359, 162-165.
11. Galang CK, Garcia-Ramirez J, Solski PA, Westwick JK, Der CJ, Neznanov NN, Oshima RG and Hauser CA. (1996). J. Biol. Chem., 271, 7992-7998.
12. Higashino F, Yoshida K, Noumi T, Seiki M and Fujinaga K. (1995). Oncogene, 10, 1461-1463.
13. Hill CS and Treisman R. (1995). Cell, 80, 199-211.
14. Hollywood DP and Hurst HC. (1993). EMBO J., 12, 2369-2375.
15. Hudson LG, Ertl AP and Gill GN. (1990). J. Biol. Chem., 265, 4389-4393.
16. Hynes NE and Stern DF. (1994). Biochem. Biophys. Acta., 1918, 165-184.
17. Iglehart JD, Kraus MH, Langton BC, Huper G, Kerns BJ and Marks JR. (1990). Cancer Res., 50, 6701-6707.
18. Janknecht R. (1996). Mol. Cell. Biol., 16, 1550-1556.
19. Jeon I-S, Davis JN, Braun BS, Sublett JE, Roussel MF, Denny CT and Shapiro DN. (1995). Oncogene, 10, 1229-1234.
20. Kaneko Y, Yoshida K, Handa M, Toyada Y, Nishihira H, Tanaka Y, Sasaki Y, Ishida S, Higashimo F and Fujinaga K. (1996). Genes. Chrom & Cancer, 15, 115-121.
21. Karim FD, Urness LD and Thummel CS. (1990). Genes & Devel., 4, 1451-1453.
22. Kaya M, Yoshida K, Higashino F, Mitaka T, Ishii S and Fujinaga. (1996). Oncogene, 12, 221-227.
23. King C, Swain SM, Porter L, Steinberg SM, Lippman ME and Gelmann EP. (1989). Cancer Res., 49, 4185-4191.
24. Kohn EC and Liotta LA. (1995). Cancer Res., 55, 1856-1862.
25. Lessnick SL, Braun BS, Denny CT and May WA. (1995). Oncogene, 10, 423-431.
26. Liu E, Thor A, He M, Barcos M, Ljung B-M and Benz C. (1992). Oncogene, 7, 1027-1032.
27. Macleod K, Leprince D and Stehelin D. (1992). Trends Biochem. Sci., 17, 251-256.
28. Matrisian LM. (1994). Ann. NY Acad. Sci. USA, 91, 10129-10133.
29. Monte D, Baert JL, Defossez PA, DeLaunott Y and Stehelin D. (1994). Oncogene, 9, 1397-1406.
30. Morgenstern JP and Land H. (1990). Nucleic Acids Res., 18, 1068.
31. Muss HB, Thor AD, Berry DA, Kute T, Liu ET, Koerner F, Cirrincione CT, Budman DR, Wood WC and Barcos M. (1994). N. Engl. J. Med., 330, 1260-1266.
32. Nerlov C, De Cesare D, Pergola F, Caracciolo A, Blasi F, Johnsen M and Verde P. (1992). EMBO J., 11, 4573-4582.
33. O'Hagan RC, Tozer RG, Symons M, McCormick F and Hassell JA. (1996). Oncogene, 13, 1323-1333.
34. Parkes HC, Lillycrop K, Howell A and Craig RK. (1990). Br. J. Cancer, 61, 39-45.
35. Pasleau F, Crooteclaes M and Gol-Winkler R. (1993). Oncogene, 8, 849-854.
36. Rorth P, Nerlov C, Blasi F and Johnsen M. (1990). Nucleic Acids Res., 18, 5009-5017.
37. Scott GK, Daniel JC, Xiong X, Maki RA, Kabat D and Benz CC. (1994). J. Biol. Chem., 269, 19848-19858.
38. Seth A, Ascione R, Fisher RJ, Mavrothalassitis GJ, Bhat NK and Papas TS. (1992). Cell Growth Diff., 3, 327-334.
39. Singleton TP and Strickler JG. (1992). Pathol. Annu., 1, 165-190.
40. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A and McGuire WL. (1987). Science, 235, 177-182.
41. Sorensen PHB, Lessnick SL, Lopez-Terrada D, Liu XF, Triche TJ and Denny CT. (1994). Nature Genetics, 6, 146-151.
42. Trimble MS, Xin J-H, Guy CT, Muller WJ and Hassell JA. (1993). Oncogene, 8, 3037-3042.
43. Tripathy D and Benz C. (1994). Hematology/Oncology Clinics of North America, 8, 29-50.
44. Urano F, Umezawa H, Hong W, Kikuchi H and Hata J-I. (1996). Biochem. Biophys. Res. Comm., 219, 608-612.
45. Wasylyk B, Hahn SL and Giovane A. (1993). Eur. J. Biochem., 211, 7-18.
46. Wright C, Nicholoson S, Angus B, Sainsbury JR, Farndon J, Cairns J, Harris AL and Home CH. (1992). Br. J. Cancer, 65, 118-121.
47. Xin J-H, Cowie A, Lachance P and Hassell JA. (1992). Genes & Develop., 6, 481-496.
48. Yang B-S, Hauser CA, Henkel G, Colman MS, Van Beveren C, Stacey KJ, Hume DA, Maki RA and Ostrowski MC. (1996). Mol. Cell. Biol., 16, 538-547.
49. Zucman J, Melot T, Desmaze C, Ghysdael J, Plougastel B, Peter M, Zucker JM, Triche TJ, Sheer D and Turc-Carel C. (1993). EMBO J., 12, 4481-4487.